Medicines Adaptive Pathways to Patients (MAPPS) – Opportunities and Challenges in Europe

Abstract

François Lucas explains the rationale and benefits of the European MAPPs initiative and analyses the challenges it is facing.

Authors

François Lucas

Full Text
Back to March/April 2015
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×